VARELISA B2 GLYCOPROTEIN I IGG ANTIBODIES, MODELS 18748 AND 18796

System,test,antibodies,b2 - Glycoprotein I (b2 - Gpi)

PHARMACIA DEUTSCHLAND GMBH

The following data is part of a premarket notification filed by Pharmacia Deutschland Gmbh with the FDA for Varelisa B2 Glycoprotein I Igg Antibodies, Models 18748 And 18796.

Pre-market Notification Details

Device IDK040449
510k NumberK040449
Device Name:VARELISA B2 GLYCOPROTEIN I IGG ANTIBODIES, MODELS 18748 AND 18796
ClassificationSystem,test,antibodies,b2 - Glycoprotein I (b2 - Gpi)
Applicant PHARMACIA DEUTSCHLAND GMBH DIAGNOSTICS DIVISION MUNZINGER STRASSE 7 Freiburg,  DE D-79111
ContactMichael Linss
CorrespondentMichael Linss
PHARMACIA DEUTSCHLAND GMBH DIAGNOSTICS DIVISION MUNZINGER STRASSE 7 Freiburg,  DE D-79111
Product CodeMSV  
CFR Regulation Number866.5660 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2004-02-20
Decision Date2004-05-11
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.